Phenoxybenzamine in Prostatic Obstruction

Abstract
A short controlled trial has confirmed that phenoxybenzamine (10 or 20 mg/day) relaxes the resting proximal urethra and reduces the voiding frequency in patients with benign prostatic hypertrophy.

This publication has 0 references indexed in Scilit: